National Eczema Association Awards Grant to Johns Hopkins University to Investigate Noa Therapeutics’ Novel Treatment for Chronic Inflammatory Diseases Newswire Canada Source link
Without these crucial microbes, babies are more likely to suffer long-term health issues Earth.com Source link
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study BioSpace Source link
Patients with Severe Chronic Hand Eczema More Willing to Allocate Time for Treatment HCP Live Source link